Ivanhoé Cambridge Buys into Genome Valley Labs Portfolio in India
Posted on 07/10/2021
India is an established pharma and life science innovation hub for global and domestic companies and the world’s largest vaccine manufacturing destination. Revealed on July 6, 2021, Ivanhoé Cambridge, a global real estate subsidiary of the Caisse de dépôt et placement du Québec, made an investment in a 0.85M sf life science R&D office-labs portfolio […]
